Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus. [1] Repaglinide is the generic name of the brand-name drug Prandin. It's used to treat people with type 2 diabetes who can't manage their condition by diet and exercise alone. Three unknown impurities and a byproduct in repaglinide bulk drug at levels below 0.1% (ranging from 0.05 to 0.1%) were detected by a simple isocratic reversed-phase high performance liquid chromatography (HPLC) method. Repaglinide received an overall rating of 8 out of 10 stars from 2 reviews. See what others have said about Repaglinide, including the effectiveness, ease of use and side effects. PRANDIN ® (repaglinide) Tablets (0.5, 1, and 2 mg) Rx only. DESCRIPTION. PRANDIN ® (repaglinide) is an oral blood glucose-lowering drug of the meglitinide class used in If you are changing from a different diabetes drug (such as chlorpropamide) to repaglinide, follow your doctor's directions carefully for stopping the old drug and starting this medication. * Final gross price and currency may vary according to local VAT and billing address. * Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. Repaglinide (Prandin) is a drug prescribed to lower blood sugar levels (glucose) in persons with diabetes. Side effects, drug interactions, warnings and precautions, and patient information should be reviewed prior to taking any medication. About MyAccess. If your institution subscribes to this resource, and you don't have a MyAccess Profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus. Three unknown impurities and a byproduct in repaglinide bulk drug at levels below 0.1% (ranging from 0.05 to 0.1%) were detected by a simple isocratic reversed-phase high performance liquid.